Write your message
Volume 10, Issue 3 (12-2020)                   cmja 2020, 10(3): 270-283 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nahayati M A, Vaghar Seyyedin S A, Bahrami-Taghanki H R, Rezaee Z, Mehrpooya N, Rahimi H. Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial. cmja 2020; 10 (3) :270-283
URL: http://cmja.arakmu.ac.ir/article-1-769-en.html
Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial
Mohammad Ali Nahayati1 , Seyed Abolfazl Vaghar Seyyedin2 , Hamid Reza Bahrami-Taghanki3 , Zahra Rezaee2 , Nasim Mehrpooya4 , Hossein Rahimi * 5
1- Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashahd, Iran.
2- Department of Nursing, School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand,Iran.
3- Department of Complementary and Chinese Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashahd, Iran.
4- Department of Nursing, School of Nursing, Neyshaboor University of Medical Sciences, Neyshaboor, Iran.
5- Department of Nursing, School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand,Iran. , hosseinrahimi92@yahoo.com
Keywords: Acupressure, Stress, Anxiety, Multiple Sclerosis
Full-Text [PDF 5400 kb]   (1820 Downloads)     |   Abstract (HTML)  (3125 Views)
Full-Text:   (5039 Views)
1. Introduction
he most common demyelinating neurological disease in the world is Multiple Sclerosis (MS) [1]. MS, in addition to physical complications, causes psychological problems such as stress and anxiety on patients [9, 10]. In Iran, the prevalence of stress and anxiety is 44.8% and 39.1%m respectively [13]. Stress and anxiety aggravate the symptoms of MS and reduce the quality of life of these patients [15, 16, 19, 20]. People with MS usually do not use anti-stress and anti-anxiety medications due to side effects and financial costs [21, 22]. Therefore, it seems that treatment methods such as acupressure should be provided to patients with MS [24]. In acupressure, to treat some diseases and induce relaxation, certain acupoints on the body skin are put under pressure with a finger or non-invasive tool [25]. The results of studies on the effect of acupressure on stress and anxiety of different patients are inconsistent [27, 28, 29, 30, 31, 32, 33, 34]. There is also no strong evidence that acupressure is effective in improving or reducing stress and anxiety in people with MS [35]. Therefore, conducting more studies to investigate the effect of acupressure on stress and anxiety in patients with MS can help to gather more evidence and expand the related knowledge. In this regard, the present study was conducted to determine the effect of acupressure on stress and anxiety in patients with MS.
2. Materials and Methods
The present study is a clinical trial conducted on 53 patients with MS. A demographic form and the Depression Anxiety Stress Scale - 42 items (DASS-42) were used for collecting data from participants before study. They were then randomly and evenly assigned to the intervention and sham groups. Participants in the intervention group were asked to apply a pressure of 2-3 kg to the Yin Tong and Shenmen acupoints using the thumb pulp [22, 23]. The method of applying pressure on the mentioned acupoints as well as the correct amount of pressure (2-3 kg were explained and taught using a digital scale. Participants were asked to perform the intervention every day from 9 to 10 am for a month, first on Shenmen acupoint of the right hand (5 minutes), then on Shenmen acupoint of the left hand (5 minutes) and finally on the Yin Tang acupoint (5 minutes). The intervention in the sham group was similar to the intervention group; the difference was that the participants in this group pressed 2.5 cm below the Shenmen acupoint (towards the arm) and 3 cm above the Yin Tong acupoint. One day after the intervention, the DASS-42 was completed again. In order to analyze the data, frequency and percentage were used for description; [aired t-test was used for within-group comparison; and independent t-test for between-group comparison and comparison of changes in mean scores of stress and anxiety.
3. Results
Before the intervention, there was no statistically significant difference between the two groups in terms of demographic variables and mean scores of stress and anxiety (P>0.05) (Table 1). 



In the intervention group, the results of paired t-test showed that the mean scores of stress and anxiety decreased significantly after acupressure (P<0.001). The results of independent t-test showed no statistically significant difference between the mean scores of stress and anxiety in the two groups after acupressure (P>0.05) (Table 1). However, comparing the changes in the mean scores of stress and anxiety between the two groups, results showed that the mean scores of stress and anxiety in the intervention group were significantly lower than in the sham group (P<0.001) (Table 2). 



4. Conclusion
The results of the present study showed that the application of acupressure in Yin Tong and Shenmen acupoints was effective in reducing stress and anxiety in patients with MS. The results of Hmwe et al. and Fassoulaki et al. are in line with the results of the present study [22, 24]. Kwan et al. and Sand-Jecklin et al. showed that the application of acupressure reduces patients’ stress [14, 15], while Honda et al. reported that acupressure does not reduce students’ stress in a short period [16]. Regarding the effect of acupressure on anxiety, Koo et al. showed that acupressure reduces anxiety in women undergoing cesarean section [25]. Mansourzadeh et al. also showed that acupressure reduces anxiety [17]. The results of Dehghan Mehr et al. and Ganak et al. are also consistent with our results [18, 19]. Howeevr, Vali et al.’s study showed that acupressure does not reduce preoperative anxiety [20].
One of the disadvantages of the present study was its relatively small sample size. The selection of samples from one center was another disadvantage. It is recommended that the effect of pressure of other acupoints in acupressure on stress and anxiety of patients with MS be investigated in future studies. It is also recommended to compare other complementary medicine methods such as aromatherapy combined with acupressure on stress and anxiety of MS patients. Applying acupressure to Shenman and Yin Tong acupoints, in addition to other medications and therapies, can reduce stress and anxiety in people with MS.
Ethical Considerations
Compliance with ethical guidelines
This study has an ethical approval (Code: IR.BUMS.REC.1398.218) and is a registered clinical trial (Code: IRCT20190515043601N5). All patients were free to leave the study at any time, and were assured of the confidentiality of their information.
Funding
This study was extracted from a MA. thesis of Zahra Rezaee, and received financial support from the Deputy for Research and Technology of Birjand University of Medical Sciences.
Authors' contributions
Conceptualization: Hossein Rahimi and Seyed Abolfazl vaghar Seyedin; Editing & review: Nasim Mehrpooya; Data analysis: Nasim Mehrpooya and Hossein Rahimi; Data collection: Zahra Rezaei; Intervention design: Hamid Reza Bahrami Taghanaki and Mohammad Ali Nahayati.
Conflicts of interest
The authors declare no conflict of interest
Acknowledgements
The authors would like to thank the Deputy for Research and Technology of Birjand University of Medical Sciences for their support, and all patients for their valuable cooperation.


References
  1. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Revue neurologique. 2016; 172(1):3-13. [DOI:10.1016/j.neurol.2015.10.006] [PMID]
  2. Gilmour H, Ramage-Morin PL, Wong SL. Multiple sclerosis: Prevalence and impact. Health Reports. 2018; 29(1):3-8. [PMID]
  3. Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. Multiple sclerosis epidemiology in Middle East and North Africa: A systematic review and meta-analysis. Neuroepidemiology. 2015; 44(4):232-44. [DOI:10.1159/000431042] [PMID]
  4. Eskandarieh S, Heydarpour P, Elhami S-R, Sahraian MA. Prevalence and incidence of multiple sclerosis in Tehran, Iran. Iranian journal of public health. 2017; 46(5):699-704. [PMID] [PMCID]
  5. Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010; 129(2):154-69. [DOI:10.1111/j.1365-2567.2009.03225.x] [PMID] [PMCID]
  6. Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). The EPMA Journal. 2016; 7(1):13. [DOI:10.1186/s13167-016-0062-6] [PMID] [PMCID]
  7. Jacquerye P, Poma JF, Dupuis M. Uhthoff’s phenomenon as the presenting symptom of Multiple Sclerosis (MS). Acta Neurologica Belgica. 2017; 117(4):953-4. [DOI:10.1007/s13760-017-0819-2] [PMID]
  8. AlBloushi AF, Dheyab AM, Al-Swaina NF, Al-Obailan M, Daif A-k, Abu El-Asrar AM. Clinical findings and outcomes of uveitis associated with multiple sclerosis. European Journal of Ophthalmology. 2020:1120672120904667. [DOI:10.1177/1120672120904667] [PMID]
  9. Nasiri M, Hosseini SH, Sakhaei SY, Tabrizi N, Yazdani Cherati J, Abedini M. [Prevalence of psychiatric disorders in patients with multiple sclerosis in Mazandaran, Iran (Persian)]. Journal of Mazandaran University of Medical Sciences. 2016; 26(140):60-70. http://jmums.mazums.ac.ir/article-1-8549-en.html
  10. Murphy R, O’Donoghue S, Counihan T, McDonald C, Calabresi PA, Ahmed MA, et al. Neuropsychiatric syndromes of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2017; 88(8):697-708. [DOI:10.1136/jnnp-2016-315367] [PMID]
  11. Simpson R, Mair FS, Mercer SW. Mindfulness-based stress reduction for people with multiple sclerosis-a feasibility randomised controlled trial. BMC Neurology. 2017; 17(1):94. [DOI:10.1186/s12883-017-0880-8] [PMID] [PMCID]
  12. Guty E, Kozimala M, Boratyn B, Mrozowicz A, Nowak P, Balicka-Adamik L. Multiple sclerosis: Psychological problems (emotional tension, stress, depressive disorders) and accompanying factors. Journal of Education, Health and Sport. 2019; 9(4):265-75. http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6810/8515
  13. Karimi S, Andayeshgar B, Khatony A. Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: A cross-sectional study. BMC Psychiatry. 2020; 20:166. [DOI:10.1186/s12888-020-02579-z] [PMID] [PMCID]
  14. Turner AP, Knowles LM. Behavioral interventions in multiple sclerosis. Federal Practitioner. 2020; 37(Suppl 1):S31-5. [PMID] [PMCID]
  15. Gilbertson RM, Klatt MD. Mindfulness in motion for people with multiple sclerosis: A feasibility study. International journal of MS care. 2017; 19(5):225-31. [DOI:10.7224/1537-2073.2015-095] [PMID] [PMCID]
  16. Khan S, Khan RA. Chronic stress leads to anxiety and depression. Annals of Psychiatry and Mental Health. 2017; 5(1):1091. https://www.jscimedcentral.com/Psychiatry/vol5issue1.php
  17. Arroll B, Kendrick T. Definition of Anxiety. Primary Care Mental Health. 2018; 20:125-37. [DOI:10.1017/9781911623038.010]
  18. Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. 2017; 372:331-41. [DOI:10.1016/j.jns.2016.11.067] [PMID]
  19. Carrigan N, Dysch L, Salkovskis PM. The impact of health anxiety in multiple sclerosis: A replication and treatment case series. Behavioural and Cognitive Psychotherapy. 2018; 46(2):148-67. [DOI:10.1017/S135246581700056X] [PMID]
  20. Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2018; 19:35-9. [DOI:10.1016/j.msard.2017.11.003] [PMID]
  21. Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: Epidemiology, aetiology, diagnosis and treatment. CNS Drugs. 2018; 32(2):117-33. [DOI:10.1007/s40263-018-0489-5] [PMID]
  22. Lynd LD, Henrich NJ, Hategeka C, Marra CA, Mittmann N, Evans C, et al. Perspectives of patients with multiple sclerosis on drug treatment: A qualitative study. International Journal of MS Care. 2018; 20(6):269-77. [DOI:10.7224/1537-2073.2017-109] [PMID] [PMCID]
  23. Sadock B, Sadock VA, Sussman N. Kaplan & Sadock’s pocket handbook of psychiatric drug treatment. 7th ed. Philadelphia: Wolters Kluwer Health; 2017. https://books.google.com/books/about/Kaplan_Sadock_s_Pocket_Handbook_of_Psych.html?id=Z_tNDwAAQBAJ
  24. Claflin SB, van der Mei IAF, Taylor BV. Complementary and alternative treatments of multiple sclerosis: A review of the evidence from 2001 to 2016. Journal of Neurology, Neurosurgery & Psychiatry. 2018; 89(1):34-41. [DOI:10.1136/jnnp-2016-314490] [PMID]
  25. Lee EJ, Frazier SK. The efficacy of acupressure for symptom management: A systematic review. Journal of Pain and Symptom Management. 2011; 42(4):589-603. [DOI:10.1016/j.jpainsymman.2011.01.007] [PMID] [PMCID]
  26. Gao D. Traditional Chinese medicine: The complete guide to acupressure, acupuncture, Chinese herbal medicine, food cures and qi gong. London: Carlton Books; 2013. https://books.google.com/books/about/Traditional_Chinese_Medicine.html?id=0rmLMQEACAAJ
  27. Rani M, Sharma L, Advani U, Kumar S. Acupressure as an Adjunct to Pharmacological Treatment for Depression, Anxiety, and Stress in Patients with Knee Osteoarthritis. Journal of Acupuncture and Meridian Studies. 2020; 13(4):129-35. [DOI:10.1016/j.jams.2020.07.001] [PMID]
  28. Kwan RYC, Leung MCP, Lai CKY. The effect of acupressure on agitation and salivary cortisol in people with dementia: A pilot study. The Journal of Alternative and Complementary Medicine. 2016; 22(11):903-10. [DOI:10.1089/acm.2016.0062] [PMID]
  29. Sand-Jecklin K, Reiser V. Use of seva stress release acupressure to reduce pain, stress, and fatigue in patients hospitalized for cancer treatment. Journal of Hospice & Palliative Nursing. 2018; 20(6):521-8. [DOI:10.1097/NJH.0000000000000484] [PMID]
  30. Honda Y, Tsuda A, Horiuchi S. Effect of a four-week self-administered acupressure intervention on perceived stress over the past month. Open Journal of Medical Psychology. 2012; 1(3):20-4. [DOI:10.4236/ojmp.2012.13004]
  31. Mansoorzadeh KH, Afazel MR, Taghadosi M, Gilasi HR. The effect of acupressure on anxiety and dysrhythmia in patients undergoing cardiac catheterization. Life Science Journal. 2014; 11(1):153-7. http://eprints.kaums.ac.ir/436/
  32. Clond M. Emotional freedom techniques for anxiety: A systematic review with meta-analysis. The Journal of Nervous and Mental Disease. 2016; 204(5):388-95. [DOI:10.1097/NMD.0000000000000483] [PMID]
  33. Genc F, Tan M. The effect of acupressure application on chemotherapy-induced nausea, vomiting, and anxiety in patients with breast cancer. Palliative & Supportive Care. 2015; 13(2):275-84. [DOI:10.1017/S1478951514000248] [PMID]
  34. Valiee S, Bassampour SS, Nasrabadi AN, Pouresmaeil Z, Mehran A. Effect of acupressure on preoperative anxiety: A clinical trial. Journal of PeriAnesthesia Nursing. 2012; 27(4):259-66. [DOI:10.1016/j.jopan.2012.05.003] [PMID]
  35. Karpatkin HI, Napolione D, Siminovich-Blok B. Acupuncture and multiple sclerosis: A review of the evidence. Evidence-Based Complementary and Alternative Medicine. 2014; 2014:972935. [DOI:10.1155/2014/972935] [PMID] [PMCID]
  36. Saccà F, Costabile T, Carotenuto A, Lanzillo R, Moccia M, Pane C, et al. The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests. Multiple Sclerosis. 2017; 23(9):1289-96. [DOI:10.1177/1352458516677592] [PMID]
  37. Lepore V, Bosetti C, Santucci C, Iaffaldano P, Trojano M, Mosconi P, et al. Detection of disability worsening in relapsing-remitting multiple sclerosis patients. A real-world roving edss-expanded disability status scale reference analysis from the Italian multiple sclerosis register. European Journal of Neurology. 2020. [DOI:10.1111/ene.14589] [PMID]
  38. Dehghan A, Memarian R. [Abundance of Stress, Anxiety and Depression in Multiple Sclerosis Patients (Persian)]. Alborz University Medical Journal. 2013; 2(2):82-8. [DOI:10.18869/acadpub.aums.2.2.82]
  39. Habibi M, Dehghani M, Pooravari M, Salehi S. Confirmatory factor analysis of Persian version of Depression, Anxiety and Stress (DASS-42): Non-clinical sample. Razavi International Journal of Medicine. 2017; 5(4):e12021. [DOI: 10.5812/RIJM.12021]
  40. Hmwe NTT, Subramanian P, Tan LP, Chong WK. The effects of acupressure on depression, anxiety and stress in patients with hemodialysis: A randomized controlled trial. International Journal of Nursing Studies. 2015; 52(2):509-18. [DOI:10.1016/j.ijnurstu.2014.11.002] [PMID]
  41. Son C-G. Clinical application of single acupoint (HT7). Integrative Medicine Research. 2019; 8(4):227-8. [DOI:10.1016/j.imr.2019.08.005] [PMID] [PMCID]
  42. Fassoulaki A, Paraskeva A, Kostopanagiotou G, Tsakalozou E, Markantonis S. Acupressure on the extra 1 acupoint: The effect on bispectral index, serum melatonin, plasma β-endorphin, and stress. Anesthesia & Analgesia. 2007; 104(2):312-7. [DOI:10.1213/01.ane.0000250911.43942.4e] [PMID]
  43. Ranabir S, Reetu K. Stress and hormones. Indian Journal of Endocrinology and Metabolism. 2011; 15(1):18-22. [DOI:10.4103/2230-8210.77573] [PMID] [PMCID]
  44. Moyer CA, Seefeldt L, Mann ES, Jackley LM. Does massage therapy reduce cortisol? A comprehensive quantitative review. Journal of Bodywork and Movement Therapies. 2011; 15(1):3-14. [DOI:10.1016/j.jbmt.2010.06.001] [PMID]
  45. Malizia E, Andreucci G, Paolucci D, Crescenzi F, Fabbri A, Fraioli F. Electroacupuncture and peripheral β-endorphin and ACTH levels. The Lancet. 1979; 314(8141):535-6. [DOI:10.1016/S0140-6736(79)91601-5] [PMID]
  46. Cabýoglu MT, Ergene N, Tan U. The mechanism of acupuncture and clinical applications. International Journal of Neuroscience. 2006; 116(2):115-25. [DOI:10.1080/00207450500341472] [PMID]
  47. Pan B, Castro-Lopes JM, Coimbra A. Activation of anterior lobe corticotrophs by electroacupuncture or noxious stimulation in the anaesthetized rat, as shown by colocalization of fos protein with ACTH and β-endorphin and increased hormone release. Brain Research Bulletin. 1996; 40(3):175-82. [DOI:10.1016/0361-9230(96)00011-1]
  48. Li SJ, Tang J, Han JS. The implication of central serotonin in electro-acupuncture tolerance in the rat. Scientia Sinica Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences. 1982; 25(6):620-9.
  49. Field T, Hernandez-Reif M, Diego M, Schanberg S, Kuhn C. Cortisol decreases and serotonin and dopamine increase following massage therapy. International Journal of Neuroscience. 2005; 115(10):1397-413. [DOI:10.1080/00207450590956459] [PMID]
  50. Lane J. The neurochemistry of counterconditioning: Acupressure desensitization in psychotherapy. Energy Psychology: Theory, Research, and Treatment. 2009; 1(1):31-44. [DOI:10.9769/EPJ.2009.1.1.JRL]
  51. Kuo S-Y, Tsai S-H, Chen S-L, Tzeng Y-L. Auricular acupressure relieves anxiety and fatigue, and reduces cortisol levels in post-caesarean section women: A single-blind, randomised controlled study. International Journal of Nursing Studies. 2016;B53:17-26. [DOI:10.1016/j.ijnurstu.2015.10.006] [PMID]
  52. Hui KKS, Marina O, Liu J, Rosen BR, Kwong KK. Acupuncture, the limbic system, and the anticorrelated networks of the brain. Autonomic Neuroscience. 2010; 157(1-2):81-90. [DOI:10.1016/j.autneu.2010.03.022] [PMID] [PMCID]
 
Type of Study: Research | Subject: Other cases
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Complementary Medicine Journal

Designed & Developed by : Yektaweb